Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance. - Wikidata - wikimedia - TriplyDB

Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance.

Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance.

http://www.wikidata.org/entity/Q35735937

about

The Growing Complexity of Cancer Cell Response to DNA-Damaging Agents: Caspase 3 Mediates Cell Death or Survival?Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic Perspectives Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth Lipid metabolic reprogramming in cancer cells Therapeutic strategies targeting cancer stem cells Non-autonomous overgrowth by oncogenic niche cells: Cellular cooperation and competition in tumorigenesis Metabolic reprogramming: the emerging concept and associated therapeutic strategies Spreading the word: non-autonomous effects of apoptosis during development, regeneration and disease Redox Regulation in Cancer Stem Cells Cyclooxygenase-2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during Therapy Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer Metastatic colonization by circulating tumour cells Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression Migration and invasion of drug-resistant lung adenocarcinoma cells are dependent on mitochondrial activity Persistence to anti-cancer treatments in the stationary to proliferating transition.Current status and perspectives of patient-derived xenograft models in cancer research.Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer Prokaryotic expression, purification and characterization of human cyclooxygenase-2.Expression levels of cleaved caspase-3 and caspase-3 in tumorigenesis and prognosis of oral tongue squamous cell carcinoma.Nutrigenomics of extra-virgin olive oil: A review.Increased HMGB1 and cleaved caspase-3 stimulate the proliferation of tumor cells and are correlated with the poor prognosis in colorectal cancer.COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset.Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors Therapy-induced tumour secretomes promote resistance and tumour progression Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity.Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression Developing multi-target therapeutics to fine-tune the evolutionary dynamics of the cancer ecosystem.Elevation of ω-3 Polyunsaturated Fatty Acids Attenuates PTEN-deficiency Induced Endometrial Cancer Development through Regulation of COX-2 and PGE2 Production Mammary Stem Cells and Tumor-Initiating Cells Are More Resistant to Apoptosis and Exhibit Increased DNA Repair Activity in Response to DNA Damage.IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel.Celecoxib reduces glucocorticoids in vitro and in a mouse model with adrenocortical hyperplasia.Onco-proteogenomics identifies urinary S100A9 and GRN as potential combinatorial biomarkers for early diagnosis of hepatocellular carcinoma.DNA Damage Response Proteins and Oxygen Modulate Prostaglandin E2 Growth Factor Release in Response to Low and High LET Ionizing Radiation.Understanding why aspirin prevents cancer and why consuming very hot beverages and foods increases esophageal cancer risk. Controlling the division rates of stem cells is an important strategy to prevent cancer.Sox4 Expression Confers Bladder Cancer Stem Cell Properties and Predicts for Poor Patient Outcome.miR-620 promotes tumor radioresistance by targeting 15-hydroxyprostaglandin dehydrogenase (HPGD).Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent RhoGDI deficiency induces constitutive activation of Rho GTPases and COX-2 pathways in association with breast cancer progression.Extracellular Reactive Oxygen Species Drive Apoptosis-Induced Proliferation via Drosophila Macrophages.

P2860

Q26749064-002D451E-A8CD-4CE3-9159-F4417F769CD9 Q26771263-F5ABEBAA-BD7B-423A-95FF-BCF87AA822B5 Q26774159-5C594501-E48F-4852-8B61-0640FFEDD047 Q26774859-BD9E96E1-B8A9-4C2C-85E4-944A8F06456B Q26781398-7F7B0CBF-172B-47B4-8E31-1A46F5F860ED Q26781414-4AF936EA-74B3-461E-B02E-CDA353DB14A9 Q26786595-44F02BE4-2E9B-4C6E-9AA3-9FFF164AB95B Q26786722-D97611B0-6D68-434B-A92D-88460CAA1274 Q26798198-E29CCDF6-9EAB-4531-AA19-D9F75D9EFA6B Q28073252-0E956632-40DC-47E5-8290-0B7D40E7FEE2 Q28076041-7F6D881C-53CA-40AA-BEF7-C89A6571B69A Q28076164-FFE794A0-0718-4737-9491-1E5EC7248DF4 Q28076686-1F17C7BA-DBE2-4C7D-8202-FCCAEBFBBAAC Q30833290-D6B7383E-3FE8-4182-817A-9E3DEF24C4F3 Q30834504-646A1BC9-2031-4381-963D-12CED0474466 Q33667686-4AF5908D-2504-41D8-A5E1-248A7D53BDD9 Q33709621-5F732544-A254-499D-998F-811F6127627C Q33783981-5DB2D68A-877C-4411-8CB0-3BC9C7FD5523 Q33888276-4AD5552C-93D5-42BE-BFFA-62A23FF7B7BE Q34539068-86D7C629-44E6-4D01-AAF1-69D9C2B8A2BC Q35658529-A03BA058-2C0E-4E23-B4EA-36EE0F09B5AF Q35818767-A2D15882-1718-475C-B511-402C960E3DCF Q35845149-C2896636-D7D5-4A78-88B3-6668A4AF197C Q35867131-7DD95859-0A26-4BC4-9EEA-18063CAB3822 Q35881186-424B49CC-15D8-434A-939F-2DD8F19E3BAF Q35921941-9E0CBA7C-785A-44A1-9F72-EA82D40A7A5A Q36021066-6F05C1E1-E031-4367-BB7A-A8477944314A Q36097745-2CEB08F2-45A8-4350-9BEA-CB0BE6AB57CB Q36163869-781BEFDD-E764-4A16-97A6-CE50B939113C Q36201008-3678C376-0295-4E39-A45C-712412721EB9 Q36266768-E3818F98-0BD0-493F-B4F1-0ACA9F9CE1A0 Q36319490-55A44D76-58A0-4597-AC10-6D27CDA795FB Q36347633-E7C369BE-80ED-4BA4-807D-8B11E0C782E4 Q36349712-54EEE8A3-BE70-4B7C-AEFA-2C74D1428903 Q36352613-51AC12C1-717B-4F70-BD8B-69E7932DA67B Q36352713-A6618984-5395-4109-BC40-2CCA9EA8A3DB Q36355984-D9A166A1-A56A-4E75-A2CA-B663E0EE9437 Q36483712-3AF6CC5C-0F0D-4901-8E05-F88445AE7C80 Q36544952-940CD955-2624-4D58-83D9-28F32F93F2D5 Q36614093-1C04061B-73AE-4230-9DF2-6702408505DB

P2860

Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance.

http://www.wikidata.org/entity/Q35735937

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance.

@ast

Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance.

@en

type

label

Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance.

@ast

Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance.

@en

prefLabel

Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance.

@ast

Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance.

@en

P1433

Q35735937-E637BFBA-FE43-4952-8E73-C393CCAA137C

P1476

Q35735937-65B32C65-BCB6-4F37-AA6D-9F5FB6CE56FD

P2093

Q35735937-17C9B8B9-2CF4-4323-9EF1-8AC31656B42C

Q35735937-2E52E839-7DB9-4CF6-921E-77957F743534

Q35735937-3811BFD7-3D87-431C-84F4-EEAAA74417AC

Q35735937-8854381A-5318-4E59-9EDD-3408E27EAD78

Q35735937-B5D09FFF-C257-4066-8525-9D5DCFBCA995

Q35735937-C6A013B9-E78A-4870-8812-DF40840BAF0E

Q35735937-C773F839-CB60-4AB7-B818-5E5C7687D326

Q35735937-DF35DE10-6517-4C5F-B155-46B0EE0DAF25

Q35735937-EF7F0D3A-E822-41B1-A247-F84280171A8B

P2860

Q35735937-0251BB7A-28AD-4B74-BD4A-3DEEC86C0A07

Q35735937-07D7423C-C9C5-431D-92A8-7434AF9AA0C0

Q35735937-0C6ABBA4-CE3B-4934-A6CC-9AF3637A577E

Q35735937-1B1F3976-E141-4B84-AB3D-176EFE90C934

Q35735937-3924C7F9-E56D-45F6-948E-22B6DDEA05D2

Q35735937-3C1F6A15-9FB5-4A01-AC54-8D6A9BFCAB7D

Q35735937-4F784E74-938F-45CD-B8A7-FDDC34FB5A68

Q35735937-5B7E6F73-ACF2-4239-B055-FA1958F9A853

Q35735937-61937FAA-5657-48ED-817C-ABC5DF60FD03

Q35735937-648B074C-64A2-4C99-BCDB-7EDE1FCEBFF6

P2888

Q35735937-3C4C1B81-6788-4E4E-BC09-28900DCE0B0C

P304

Q35735937-7EDA8B8E-6077-4FB5-9288-9A1DFE5075B6

P31

Q35735937-64DDD665-C3D2-4F36-8F75-2CE47968EF75

P356

Q35735937-E246C20D-5B12-4654-8472-D79F89AADFE5

P407

Q35735937-0702508D-9D73-4E57-83E3-3062AC266705

P433

Q35735937-D851A8D9-3D93-4BBD-8C3A-D751BABC97B1

P478

Q35735937-1E3F5B6D-270E-4A6B-8C23-F78494E3AB4C

P50

Q35735937-141ECB49-90B1-4558-84E3-7BE48775F8F4

Q35735937-B7E87EA0-FD91-48AB-8717-4D3D856A4491

P577

Q35735937-F58FC30E-2A8B-40F6-8AD8-3028A2C0BAA3

P6179

Q35735937-793772CB-5AAC-4373-B6B0-C1BC345B4425

P698

Q35735937-7FEBB9ED-E041-48E3-BA3D-1DC10987473D

P932

Q35735937-2B41929F-D674-4734-9879-BA10444482EC

P356

P1433

P1476

Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance.

@en

P2093

Antonina V Kurtova

http://www.w3.org/2001/XMLSchema#string

Erica Lay

http://www.w3.org/2001/XMLSchema#string

Fengju Chen

http://www.w3.org/2001/XMLSchema#string

Jing Xiao

http://www.w3.org/2001/XMLSchema#string

Keith Syson Chan

http://www.w3.org/2001/XMLSchema#string

Philip Levy Ho

http://www.w3.org/2001/XMLSchema#string

Qianxing Mo

http://www.w3.org/2001/XMLSchema#string

Senthil Pazhanisamy

http://www.w3.org/2001/XMLSchema#string

Seth P Lerner

http://www.w3.org/2001/XMLSchema#string

P2860

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

Normal and neoplastic urothelial stem cells: getting to the root of the problem

Bladder cancer in 2011: the dawn of personalized medicine

Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

Tissue repair and stem cell renewal in carcinogenesis

A restricted cell population propagates glioblastoma growth after chemotherapy

Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis

Isolation, cultivation and characterization of adult murine prostate stem cells

P2888

P304

209-213

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE14034

http://www.w3.org/2001/XMLSchema#string

P407

P433

7533

http://www.w3.org/2001/XMLSchema#string

P478

517

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1029467414

http://www.w3.org/2001/XMLSchema#string

P698

25470039

http://www.w3.org/2001/XMLSchema#string

P932

4465385

http://www.w3.org/2001/XMLSchema#string